fingers crossed mate, but i dont think we'll see any movement on a deal front until further/final data is released? At least not on PD1-Vaxx noting that the new Aus/UK trial has only just kicked off?
But a detailed summary on HER-Vaxx i think is long overdue for shareholders. Both trials no longer recruiting, data still being presented, there is research for new variants still on-going and the trials are almost completed. So, what's next? Not an unreasonable question.
Might even ask the company directly.
Media Thread, page-12142
-
- There are more pages in this discussion • 2,193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.001(0.88%) |
Mkt cap ! $420.8M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.6¢ | $724.5K | 12.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 135579 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 948767 | 25 |
View Market Depth
| Last trade - 13.31pm 26/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |